News

3Novices : Cadila gains after FDA nod for sclerosis treatment drug

Cadila Healthcare rose 2.26% to Rs 542.15 at 9:17 IST on BSE after the company said it has received tentative approval from the US drug regulator to market Fingolimod Capsules, 0.5 mg. http://ift.tt/2uzhRWrTwitter 3Novices
Advertisements
Standard

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s